Edison Investment Research publishes Executive Interview with Rahul Agrawal, CMO and Head of R&D; and Björn Dahlöf, CSO, Cereno Scientific
Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that an Executive Interview with members of Cereno’s executive management team has been published by equity research company Edison Investment Research, that recently published its first, in-depth research on the company.On Monday morning, Edison released a video interview, where Soo Romanoff, healthcare managing director of Edison Group, interviews Rahul Agrawal, CMO, and Björn Dahlöf, CSO, discussing the Cereno Scientifics innovative